from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0886/fprB

LFCtreatmentdescriptionclass of inhibitor

0.947

Amikacinug/mL Amikacintranslation

1.327

Cap5-10ug/mL Capreomycintranslation

1.271

Rox10-50 ug/mL Roxithromycintranslation

0.139

SM2-5 ug/mL Streptomycintranslation

1.635

Tet5-10 ug/mL Tetracyclinetranslation

0.425

Rif0.2-5ug/mL Rifampicintranscription

0.340

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.977

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.678

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.117

CPZ10-50 ug/mL Chlorpromazinerespiration

0.447

Clofazimine10-13 ug/mL Clofaziminerespiration

0.407

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.091

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.346

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.930

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.419

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.777

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.053

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.587

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.182

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.091

KCN5-20 ug/mL Potassium cyaniderespiration

0.360

NaN30.2-2 mM Sodium aziderespiration

0.013

Nigericin50 uM Nigericinrespiration

-0.115

TRC10-150 ug/mL Triclosanrespiration

0.354

TRZ10-25 ug/mL Thioridazinerespiration

0.078

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.978

menadione6-10 ug/mL Menadionerespiration

3.272

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.649

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.689

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.767

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.264

NRP_1Non-replicating persistence stage 1dosRassociated

-0.380

Amp0.2mg/mL AmpicillincellWall

0.073

Cephalexin20-100 ug/mL CephalexincellWall

-0.757

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.091

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.189

EMB10-20 ug/mL EthambutolcellWall

1.367

Eta12-40 ug/mL EthionamidecellWall

1.268

INH0.2-0.4 ug/mL IsoniazidcellWall

1.119

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.225

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.070

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.898

BZA0.12 mg/mL BenzamidearomaticAmides

-0.333

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.723

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.407

H2O24 mM hydrogen peroxideDNAdamaging

-0.257

Levo10 ug/mL LevofloxacinDNAdamaging

-0.299

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.463

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.610

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.158

UVUV-irradiationDNAdamaging

-0.027

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.902

Antimycin12.5-50 ug/mL Antimycin A?

-0.335

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.842

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.829

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.125

PA8240.2-2 ug/mL PA-824?

1.129

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.524

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.024

Verapamil50 uM Verapamil?

-0.578

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.354

methoxatin10-20 ug/mL Methoxatin?